EGLN2 (NM_053046) Human Mass Spec Standard

CAT#: PH306152

EGLN2 MS Standard C13 and N15-labeled recombinant protein (NP_444274)



  View other "EGLN2" proteins (6)

Need it in bulk or customized?
Get a free quote

CNY 19,520.00


货期*
4周

规格
    • 10 ug

Product images

经常一起买 (2)
EGLN2 mouse monoclonal antibody, clone OTI7H3 (formerly 7H3)
    • 100 ul

CNY 1,999.00
CNY 2,700.00


Transient overexpression lysate of egl nine homolog 2 (C. elegans) (EGLN2), transcript variant 3
    • 100 ug

CNY 3,080.00

Specifications

Product Data
Description EGLN2 MS Standard C13 and N15-labeled recombinant protein (NP_444274)
Species Human
Expression Host HEK293
Expression cDNA Clone or AA Sequence RC206152
Predicted MW 43.7 kDa
Protein Sequence
Tag C-Myc/DDK
Purity > 80% as determined by SDS-PAGE and Coomassie blue staining
Concentration >0.05 µg/µL as determined by microplate BCA method
Labeling Method Labeled with [U- 13C6, 15N4]-L-Arginine and [U- 13C6, 15N2]-L-Lysine
Buffer 25 mM Tris-HCl, 100 mM glycine, pH 7.3
Reference Data
RefSeq NP_444274
RefSeq Size 2264
RefSeq ORF 1221
Synonyms EIT-6; EIT6; HIF-PH1; HIFPH1; HPH-1; HPH-3; PHD1
Locus ID 112398
Cytogenetics 19q13.2
Summary The hypoxia inducible factor (HIF) is a transcriptional complex that is involved in oxygen homeostasis. At normal oxygen levels, the alpha subunit of HIF is targeted for degration by prolyl hydroxylation. This gene encodes an enzyme responsible for this post-translational modification. Alternative splicing results in multiple transcript variants. Read-through transcription also exists between this gene and the upstream RAB4B (RAB4B, member RAS oncogene family) gene. [provided by RefSeq, Feb 2011]
Protein Families Druggable Genome
Protein Pathways Pathways in cancer, Renal cell carcinoma
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Documents

Other Versions

Customer Reviews 
Loading...